Arguably, these models provide a holistic view of the paradigms of hedgehog signaling networks involving GLI regulation at the SMO level or beyond and may be more relevant to current therapeutic strategies involving the development of SMO and GLI inhibitors for treating Hh-dependent cancers. The gene discussed is GLI1; the disease is cancer.